2018 Q1 Form 10-Q Financial Statement

#000114420418025403 Filed on May 04, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $96.46M $84.12M
YoY Change 14.66% 14.17%
Cost Of Revenue $5.800M $3.700M
YoY Change 56.76% -5.13%
Gross Profit $90.70M $80.50M
YoY Change 12.67% 15.33%
Gross Profit Margin 94.03% 95.69%
Selling, General & Admin $61.60M $58.60M
YoY Change 5.12% 20.82%
% of Gross Profit 67.92% 72.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.600M $1.600M
YoY Change 0.0% 6.67%
% of Gross Profit 1.76% 1.99%
Operating Expenses $74.86M $69.49M
YoY Change 7.73% 25.2%
Operating Profit $21.60M $14.63M
YoY Change 47.59% 2.49%
Interest Expense $500.0K $200.0K
YoY Change 150.0% 100.0%
% of Operating Profit 2.32% 1.37%
Other Income/Expense, Net $852.0K $2.776M
YoY Change -69.31% 73.5%
Pretax Income $22.45M $17.41M
YoY Change 28.95% 8.83%
Income Tax $2.110M $834.0K
% Of Pretax Income 9.4% 4.79%
Net Earnings $20.34M $16.58M
YoY Change 22.71% 68.28%
Net Earnings / Revenue 21.09% 19.7%
Basic Earnings Per Share $0.39 $0.32
Diluted Earnings Per Share $0.38 $0.31
COMMON SHARES
Basic Shares Outstanding 52.74M 52.60M
Diluted Shares Outstanding 54.01M 53.96M

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $178.6M $154.9M
YoY Change 15.3% -9.73%
Cash & Equivalents $103.2M $87.09M
Short-Term Investments $75.50M $67.80M
Other Short-Term Assets $9.600M $12.40M
YoY Change -22.58% -1.59%
Inventory
Prepaid Expenses
Receivables $117.2M $96.35M
Other Receivables $0.00 $0.00
Total Short-Term Assets $305.5M $263.6M
YoY Change 15.89% -3.36%
LONG-TERM ASSETS
Property, Plant & Equipment $40.40M $36.57M
YoY Change 10.47% 28.39%
Goodwill $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.00M $952.0K
YoY Change 8933.61% -42.34%
Total Long-Term Assets $135.0M $134.6M
YoY Change 0.28% 17.31%
TOTAL ASSETS
Total Short-Term Assets $305.5M $263.6M
Total Long-Term Assets $135.0M $134.6M
Total Assets $440.5M $398.2M
YoY Change 10.61% 2.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.50M $10.20M
YoY Change 61.76% 181.61%
Accrued Expenses $45.20M $41.10M
YoY Change 9.98% 490.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $69.60M $57.42M
YoY Change 21.22% -28.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $64.20M $2.117M
YoY Change 2932.59% 10.66%
Total Long-Term Liabilities $64.20M $2.117M
YoY Change 2932.59% 10.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.60M $57.42M
Total Long-Term Liabilities $64.20M $2.117M
Total Liabilities $133.8M $113.5M
YoY Change 17.93% -9.02%
SHAREHOLDERS EQUITY
Retained Earnings $296.0M
YoY Change 9.94%
Common Stock $205.3M
YoY Change 14.15%
Preferred Stock
YoY Change
Treasury Stock (at cost) $213.7M
YoY Change 15.81%
Treasury Stock Shares 6.849M shares 6.982M shares
Shareholders Equity $306.6M $284.7M
YoY Change
Total Liabilities & Shareholders Equity $440.5M $398.2M
YoY Change 10.62% 2.75%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $20.34M $16.58M
YoY Change 22.71% 68.28%
Depreciation, Depletion And Amortization $1.600M $1.600M
YoY Change 0.0% 6.67%
Cash From Operating Activities $3.692M -$1.784M
YoY Change -306.95% -106.81%
INVESTING ACTIVITIES
Capital Expenditures $6.810M $1.307M
YoY Change 421.04% -230.7%
Acquisitions
YoY Change
Other Investing Activities -$3.900M -$9.000M
YoY Change -56.67% -53.37%
Cash From Investing Activities -$10.74M -$10.31M
YoY Change 4.24% -48.98%
FINANCING ACTIVITIES
Cash Dividend Paid $6.959M $5.374M
YoY Change 29.49%
Common Stock Issuance & Retirement, Net $0.00 $1.304M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.29M -$15.91M
YoY Change -3.91% 253.51%
NET CHANGE
Cash From Operating Activities 3.692M -$1.784M
Cash From Investing Activities -10.74M -$10.31M
Cash From Financing Activities -15.29M -$15.91M
Net Change In Cash -21.64M -$28.00M
YoY Change -22.7% -1966.6%
FREE CASH FLOW
Cash From Operating Activities $3.692M -$1.784M
Capital Expenditures $6.810M $1.307M
Free Cash Flow -$3.118M -$3.091M
YoY Change 0.87% -111.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
322000 USD
CY2017Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2542000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
20340000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
16576000 USD
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26372000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26302000 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27006000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26981000 shares
CY2018Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2017Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
22450000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17410000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2110000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
834000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21039000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16748000 USD
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1555000 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1566000 USD
CY2018Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-74000 USD
CY2017Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-129000 USD
CY2018Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
561000 USD
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
458000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6289000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5655000 USD
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-815000 USD
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
426000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7700000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9395000 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5520000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2974000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
36000 USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-40000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1829000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3000 USD
CY2018Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12383000 USD
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12491000 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-390000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1479000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3692000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1784000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6810000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1307000 USD
CY2018Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
8000000 USD
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10744000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10307000 USD
CY2018Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8637000 USD
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9517000 USD
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1304000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
310000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
287000 USD
CY2018Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
6959000 USD
CY2017Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
5374000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15286000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15908000 USD
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
696000 USD
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
118000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-21642000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27881000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114967000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87086000 USD
CY2018Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
11934000 USD
CY2017Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9000000 USD
CY2018Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
139614000 USD
CY2018Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
65611000 USD
CY2018Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
65611000 USD
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
134696000 USD
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
59050000 USD
CY2018Q1 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
47927000 USD
CY2018Q1 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
28004000 USD
CY2018Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
75931000 USD
CY2018Q1 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
47725000 USD
CY2018Q1 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
27760000 USD
CY2018Q1 us-gaap Trading Securities
TradingSecurities
58058000 USD
CY2017Q4 us-gaap Trading Securities
TradingSecurities
53350000 USD
CY2018Q1 expo Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
65611000 USD
CY2017Q4 expo Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
59050000 USD
CY2017Q1 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
1898000 USD
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
678000 USD
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
446000 USD
CY2018Q1 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7643000 USD
CY2017Q1 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6910000 USD
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
299000 USD
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
405000 USD
CY2017Q4 us-gaap Assets
Assets
439589000 USD
CY2018Q1 us-gaap Assets
Assets
440459000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1330000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2029000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
440459000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
439589000 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
74859000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
69488000 USD
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
852000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2776000 USD
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3805000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3526000 USD
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2018Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6849000 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7084000 shares
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">Use of Estimates. <font style="FONT-WEIGHT: normal">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2016Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2017Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
22666 shares
CY2017Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1304000 USD
CY2018Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
45376000 USD
CY2018Q1 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2017Q1 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2017Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5416000 USD
CY2017 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21638000 USD
CY2018Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
CY2018Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6700000 USD
CY2018Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
179083000 USD
CY2018Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0 USD
CY2018Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
446000 USD
CY2018Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
178637000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
196791000 USD
CY2017Q4 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0 USD
CY2017Q4 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
393000 USD
CY2017Q4 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
196398000 USD
CY2017Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2017Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2017Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2017Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2017 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.84
CY2017Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5374000 USD
CY2017Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5424000 USD
CY2017Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5424000 USD
CY2018Q1 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-305000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6071000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
9742000 USD
CY2017Q4 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
59050000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
592592 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
198846 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
267760 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
523678 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
45.91
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
80.14
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
54.28
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
54.63
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y3M18D
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
41187000 USD
CY2018Q1 us-gaap Share Price
SharePrice
78.65
CY2018Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2604000 USD

Files In Submission

Name View Source Status
0001144204-18-025403-index-headers.html Edgar Link pending
0001144204-18-025403-index.html Edgar Link pending
0001144204-18-025403.txt Edgar Link pending
0001144204-18-025403-xbrl.zip Edgar Link pending
expo-20180330.xml Edgar Link completed
expo-20180330.xsd Edgar Link pending
expo-20180330_cal.xml Edgar Link unprocessable
expo-20180330_def.xml Edgar Link unprocessable
expo-20180330_lab.xml Edgar Link unprocessable
expo-20180330_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv491650_10q.htm Edgar Link pending
tv491650_ex31-1.htm Edgar Link pending
tv491650_ex31-2.htm Edgar Link pending
tv491650_ex32-1.htm Edgar Link pending
tv491650_ex32-2.htm Edgar Link pending